Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

NeuroMetrix Reports Progress on Quell Availability within the Veterans Health Administration

NeuroMetrix,Inc.
Posted on: 20 Sep 16

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported today on multiple efforts to increase the availability of Quell® Wearable Pain Relief Technology™ to veterans who suffer from chronic pain through the Veterans Health Administration.

The Company has successfully completed its registration process in the U.S. federal government's System for Award Management (SAM), a requirement for selling products to any federal government entity including the Veterans Health Administration.

NeuroMetrix is also partnering with Marathon Medical Corporation, a Service Disabled Veterans Owned Small Business (SDVOSB) and medical supply distribution company, to provide Quell to veterans through the Veterans Health Administration.

“While our core strategy is to offer Quell directly to consumers, we are also committed to identifying distribution channels that expand the number of people who have access to the technology,” said Shai Gozani, M.D., Ph.D., President and CEO of Neurometrix. “Since participating in a VA Health Summit in May 2016, we’ve been aware of the VA’s commitment to identifying alternative approaches to pain management. We are hopeful that relationships with Marathon Medical as well as individual VA facilities will increase opportunities for veterans to try Quell for pain relief.”

“We are always looking to add innovative products to our offering,” said John St. Leger, President and CEO of Marathon Medical Corporation. “We will utilize our expertise in delivering medical supplies into the VA to expand access to Quell for veterans.”

Quell can provide widespread relief from chronic pain for veterans like Gerard DeWind, who is excited to be among the first veterans to access Quell through his local VA hospital. “I have chronic pain including arthritis in my right ankle. I was attracted to Quell for its potential to help me sleep better and give me a better quality of life.”

About Marathon Medical Corporation

Marathon Medical is a medical supply distribution company founded in 2002. The company’s mission is to provide excellence and professional personal service in the healthcare supply chain. Marathon Medical’s corporate office and one warehouse are located near Denver, CO with an additional location in Tampa, FL. Visit Marathon Medical for more information.

About Quell

Quell is designed for millions of people suffering from chronic pain. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. In a recent study, 81% of Quell users reported an improvement in their chronic pain. Quell users can start, stop, and adjust therapy discreetly via the optional Quell Relief app. Quell also offers advanced sleep tracking that provides feedback on eight dimensions of sleep including sleep duration, quality, body position, time out of bed, and repetitive leg movements throughout the night. Quell was the winner of the 2016 SXSW (South by Southwest) Innovation Award for Best Wearable Technology. For more information, visit QuellRelief.com.

About NeuroMetrix

NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company’s lead product is Quell, an over-the-counter wearable therapeutic device for chronic pain. Quell is integrated into a digital health platform that helps patients optimize their therapy and decrease the impact of chronic pain on their quality of life. The company also markets DPNCheck®, a rapid point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. The company maintains an active research effort and has several pipeline programs, including a therapeutic device for restless leg syndrome. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160920005302/en/

Business Wire
www.businesswire.com

Last updated on: 20/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.